Abstract

This study investigated whether pilocarpine and cyclopentolate induce changes in ocular biometry of guinea pigs, in order to understand if guinea pigs have a similar response to these two agents as humans do. Under general anaesthesia, refraction, axial components and surface curvature in various optical interfaces of the eye were measured in 10 guinea pigs (age of 2weeks) at baseline (0min) and different time points (5, 10, 20, 30, 60, 90min) after topical administration of pilocarpine or cyclopentolate. The interval between the two drug treatments for the same animals was at least 24h. Eyes treated with pilocarpine developed approximately 6D myopia (p<0.001 from 0 to 90min) with a decrease in anterior lens radius of curvature (ALRC) (p<0.001 from 0 to 90min, repeated measures anova). This myopic shift was moderately correlated to the decreased ALRC (r(2) =0.48, p<0.001). Furthermore, a small but significant increase in the VCD (p<0.001 from 0 to 30min, repeated measures anova) with an unchanged AL (p=0.85 from 0 to 90min, repeated measures anova) after the drug treatment suggested a transient and mild forward movement of the lens. Cyclopentolate dilated the pupil in all eyes (p<0.001 from 0 to 90min, repeated measures anova) but did not change other ocular parameters. The muscarinic agonist, pilocarpine induced a myopic shift mainly due to a decrease in ALRC, suggesting that guinea pigs have an accommodative mechanism similar to that in humans. The minimal changes produced by cyclopentolate could be due to the use of general anaesthesia, which may have reduced the susceptibility of the eye to topical cyclopentolate in the induction of cycloplegia.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.